Mercier Johanna sold $390K of GILD
Mercier Johanna (Chief Comm & Corp Aff Officer) sold 3,000 shares of GILEAD SCIENCES, INC. (GILD) at $129.92 ($0.39M total) on 2026-07-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on an officer’s scheduled open-market sale but does not introduce new company fundamentals.
Market read
Traders may treat this as routine insider activity with minimal impact unless paired with other new catalysts.
What to watch
The article does not state whether the sale was part of a larger scheduled program, nor does it provide context on total holdings changes beyond the post-transaction share count.
Background
The article is an SEC Form 4 insider transaction disclosure for Gilead Sciences, Inc.
Ticker impact
SEC Form 4 shows Gilead officer Mercier Johanna sold 3,000 shares on 2026-07-15 for about $389,758 under a 10b5-1 plan.
Likely negligible near-term price impact; any effect would be sentiment-only and small.
The filing is an open-market sale by an officer, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operational, financial, or regulatory information.
Market effects
No sector read-through; this is company-specific insider transaction data without new guidance or events.
None.
None.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with internal caution, so traders may watch for follow-on filings or changes in selling pace.
Key entities
- issuerGilead Sciences, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderMercier Johanna
Chief Comm & Corp Aff Officer who sold shares.
- trading mechanism10b5-1 plan
Pre-arranged plan cited as Yes, indicating the sale was scheduled.
